APA (7th ed.) Citation

RE, C., DJ, B., ZA, R., SW, K., PH, K., DM, P., & W, M. V. (2017). Effects of the Janus Kinase Inhibitor, Tofacitinib, on Testicular Leydig Cell Hyperplasia and Adenoma in Rats, and on Prolactin Signaling in Cultured Primary Rat Leydig Cells. Toxicological sciences : an official journal of the Society of Toxicology, 155(1), 148. https://doi.org/10.1093/toxsci/kfw197

Chicago Style (17th ed.) Citation

RE, Chapin, Ball DJ, Radi ZA, Kumpf SW, Koza-Taylor PH, Potter DM, and Mark Vogel W. "Effects of the Janus Kinase Inhibitor, Tofacitinib, on Testicular Leydig Cell Hyperplasia and Adenoma in Rats, and on Prolactin Signaling in Cultured Primary Rat Leydig Cells." Toxicological Sciences : An Official Journal of the Society of Toxicology 155, no. 1 (2017): 148. https://doi.org/10.1093/toxsci/kfw197.

MLA (9th ed.) Citation

RE, Chapin, et al. "Effects of the Janus Kinase Inhibitor, Tofacitinib, on Testicular Leydig Cell Hyperplasia and Adenoma in Rats, and on Prolactin Signaling in Cultured Primary Rat Leydig Cells." Toxicological Sciences : An Official Journal of the Society of Toxicology, vol. 155, no. 1, 2017, p. 148, https://doi.org/10.1093/toxsci/kfw197.